While the end of active cancer treatment may bring some relief, it can also bring many questions and anxieties for young patients and their families.
In this Cancer Conversations podcast episode, Lisa Diller, MD, chief medical officer of the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, discusses topics around fertility, growth, late effects of treatment, and other important concerns families often face when a child finishes cancer treatment.
Listen to the podcast episode below or click “download” to listen later. Subscribe options are also available via iTunes, Google Play and RSS.
The Cancer Conversations series features Q&A-style conversations with Dana-Farber physicians, clinicians, and researchers. Topics include breast cancer research, precision cancer medicine, integrative therapies, cancer genetics, and more. Visit the Cancer Conversations page for more episodes and the Dana-Farber podcast page for more cancer podcast series.